These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 11179339)
21. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12. Kranzer K; Bauer M; Lipford GB; Heeg K; Wagner H; Lang R Immunology; 2000 Feb; 99(2):170-8. PubMed ID: 10692033 [TBL] [Abstract][Full Text] [Related]
22. Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta. Rothenfusser S; Hornung V; Krug A; Towarowski A; Krieg AM; Endres S; Hartmann G Eur J Immunol; 2001 Dec; 31(12):3525-34. PubMed ID: 11745372 [TBL] [Abstract][Full Text] [Related]
23. Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4 Chiodetti AL; Sánchez Vallecillo MF; Dolina JS; Crespo MI; Marin C; Schoenberger SP; Allemandi DA; Palma SD; Pistoresi-Palencia MC; Morón G; Maletto BA Front Immunol; 2018; 9():2319. PubMed ID: 30364187 [TBL] [Abstract][Full Text] [Related]
24. Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model. Near KA; Stowers AW; Jankovic D; Kaslow DC Infect Immun; 2002 Feb; 70(2):692-701. PubMed ID: 11796601 [TBL] [Abstract][Full Text] [Related]
25. T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells. Hofmann C; Dunger N; Grunwald N; Hämmerling GJ; Hoffmann P; Schölmerich J; Falk W; Obermeier F Gut; 2010 Oct; 59(10):1347-54. PubMed ID: 20732920 [TBL] [Abstract][Full Text] [Related]
26. Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons. Sun S; Zhang X; Tough D; Sprent J Springer Semin Immunopathol; 2000; 22(1-2):77-84. PubMed ID: 10944802 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host. Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Klinman D; Berzofsky JA J Immunol; 2006 Nov; 177(9):6336-43. PubMed ID: 17056564 [TBL] [Abstract][Full Text] [Related]
28. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif. Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000 [TBL] [Abstract][Full Text] [Related]
29. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Sedegah M; Finkelman F; Hoffman SL Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10700-2. PubMed ID: 7938013 [TBL] [Abstract][Full Text] [Related]
30. CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response. Sfondrini L; Besusso D; Bronte V; Macino B; Rossini A; Colombo MP; Ménard S; Balsari A Cancer Immunol Immunother; 2004 Aug; 53(8):697-704. PubMed ID: 15034674 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. Hayashi T; Rao SP; Takabayashi K; Van Uden JH; Kornbluth RS; Baird SM; Taylor MW; Carson DA; Catanzaro A; Raz E Infect Immun; 2001 Oct; 69(10):6156-64. PubMed ID: 11553555 [TBL] [Abstract][Full Text] [Related]
32. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. Ballas ZK; Rasmussen WL; Krieg AM J Immunol; 1996 Sep; 157(5):1840-5. PubMed ID: 8757300 [TBL] [Abstract][Full Text] [Related]
33. Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice. Sakai T; Hisaeda H; Nakano Y; Zhang M; Takashima M; Ishii K; Maekawa Y; Matsumoto S; Nitta Y; Miyazaki Ji; Yamamoto S; Himeno K Vaccine; 2003 Mar; 21(13-14):1432-44. PubMed ID: 12615440 [TBL] [Abstract][Full Text] [Related]
34. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923 [TBL] [Abstract][Full Text] [Related]
35. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides. Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y Front Immunol; 2018; 9():783. PubMed ID: 29720976 [TBL] [Abstract][Full Text] [Related]
36. Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. Paget C; Bialecki E; Fontaine J; Vendeville C; Mallevaey T; Faveeuw C; Trottein F J Immunol; 2009 Feb; 182(4):1846-53. PubMed ID: 19201836 [TBL] [Abstract][Full Text] [Related]
37. CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications. Becker Y Virus Genes; 2005 Mar; 30(2):251-66. PubMed ID: 15744581 [TBL] [Abstract][Full Text] [Related]
38. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection. Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075 [TBL] [Abstract][Full Text] [Related]
39. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194 [TBL] [Abstract][Full Text] [Related]
40. Role of interferon-gamma during CpG oligodeoxynucleotide-adjuvanted immunization with recombinant proteins. Rosa DS; Bastos KR; Bargieri DY; Tzelepis F; Nomizo A; Russo M; Soares IS; Rodrigues MM Vaccine; 2007 Aug; 25(32):6007-17. PubMed ID: 17629370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]